Emergence Global Enterprises Inc (CE) (ELOAF) Quote

Bill Chaaban is Cowering behind his wife and Mosads trolls some leader

https://twitter.com/fitx_investguy/status/1704247018690847068?t=JmYFEy_m7zNHm2m6Ngs9yA&s=19

@HopeLefeber
If Bill or Bahige Chaaban can't pay back investors Lamia has to go for facilitating all I know it was not Joel Stohlman. $fitx $cenbf $emrg $eloaf @GaryGensler @BCSCInvestRight @globeandmail
#lamiachaaban #ACMPR $CSOC $QMKR 45 MILLION ON S 1 AS EXPENSES 🤬

@GeorgeASharp How come Canada @BCSCInvestRight got it right dealing with Lamia & Bill Chaaban $fitx group and halted emrg/eloaf the third spin not counting $cenbf they say they have 45 million in business expenses @globeandmail @HopeLefeber Joel Stohlman is Chaaban patsy imo

? Bill posted https://www.facebook.com/groups/fitxcenbiobreed/?ref=share&mibextid=NSMWBT

This is so Bill https://tenor.com/view/homer-simpson-disappears-bush-hiding-gif-23712781

What happened with The Joel Stohlman case? Another of the Chaaban family stocks was halted and they cant blame Joel for that one Canada put the kibosh on that one and why is Joe Still practicing law?

They mentioned Fitx as a big reason

DID YOU SEE THE RESIGNATIONS IN THE ANNUAL CEN BIOTECH REPORT?
WHAT IS IT WITH THIS COMPANY FIRST FITC THEN EMRG NOW THIS! ARE YOU READING ALL THIS OMG SMH THIS IS TERRIBLE ALREADY!!! https://www.otcmarkets.com/otcapi/company/financial-report/366921/content

https://www.otcmarkets.com/otcapi/company/financial-report/366921/content

https://www.otcmarkets.com/otcapi/company/financial-report/366921/content

currently considering several development projects.

For further information on the Company, please contact Joseph Byrne, Chief Executive Officer and a Director at phone: 519-257-0460 or by email at: joe@emergenceglobalinc.com.

Cautionary Statement Regarding Forward-Looking Information

Forward-Looking Statements
This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to closing and the terms and conditions of the proposed transaction; the business and operations of the Company after closing the proposed transaction. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to general business, economic, competitive, political, and social uncertainties; delay or failure to receive board, shareholder, or regulatory approvals; and the uncertainties surrounding the nutraceutical and botanical industry. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. There can be no assurance that the proposed transaction will occur or that the anticipated financial, economic, or strategic benefits will be realized.

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) nor OTC Markets accepts responsibility for the adequacy or accuracy of this press release.

Brian S. Payne
Emergence Global Enterprises Inc.
+1 519-981-0970

The telephone numbers are in the links call the regulators and ask yourself.

Emergence Global Enterprises Inc. ("Emergence") is an acquirer, creator, and builder of reputable natural health consumer foods, products, and brands. Emergence has become a North American developer and distributor of branded natural health foods, supplements, and sports nutrition specialty supplements. The Company is currently considering several development projects.

For further information on the Company, please contact Joseph Byrne, Chief Executive Officer and a Director at phone: 519-257-0460 or by email at: joe@emergenceglobalinc.com.

Cautionary Statement Regarding Forward-Looking Information

Forward-Looking Statements
This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to closing and the terms and conditions of the proposed transaction; the business and operations of the Company after closing the proposed transaction. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to general business, economic, competitive, political, and social uncertainties; delay or failure to receive board, shareholder, or regulatory approvals; and the uncertainties surrounding the nutraceutical and botanical industry. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. There can be no assurance that the proposed transaction will occur or that the anticipated financial, economic, or strategic benefits will be realized.

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) nor OTC Markets accepts responsibility for the adequacy or accuracy of this press release.

Brian S. Payne
Emergence Global Enterprises Inc.
+1 519-981-0970
email us here

Brian Payne

https://www.marketscreener.com/business-leaders/Brian-Payne-0HGQH6-E/biography/

For further information about IIROC's trading halt policy, please see Trading Halts & Timely Disclosure (https://www.iiroc.ca/news-and.../halts-and-resumptions) at www.iiroc.ca under the Halts and Resumptions tab. Please note that IIROC staff cannot provide any information about a specific halt beyond what is contained in this halt notice. For general information about IIROC, contact IIROC's Complaints and Inquiries team at inquiries@iiroc.ca or 1-877-442-4322 (Option 2). For company-related enquiries, contact the company directly.

HALTED They missed 3 mandatory financial filings seems like the Bsbc regulators are putting a dent in the emrg/eloaf plans for vertical integration 3 filings these clowns miss

CEASE TRADED REPORTING ISSUERS LIST | BCSC
https://www.bcsc.bc.ca/industry/issuer-regulation/...

View a PDF of the BCSC Cease Traded Reporting Issuers List. Note: List below shows the company or person (s) that are currently cease traded or management cease traded; to view a complete listing select their name. Cease Traded Reporting Issuers List Updated as of 2023-03-07 12:00:00 AM Issuer Name Principal CTO MCTO View Results

https://www.bcsc.bc.ca/.../2023/2023-BCSECCOM-107.pdf...

.ca/-/media/PWS/New-Resources/Decision-and-Orders/Cease-Trade-Orders/2023/2023-BCSECCOM-107.pdf?dt=20230306225000

Emergence Global Enterprises Inc. (the Issuer) Under the securities legislation of British Columbia and Ontario (Legislation) Background ¶ 1 This is the order of the regulator of the British Columbia Securities Commission (the Principal Regulator) and evidences the decision of the regulator or securities regulatory authority in Ontario (each a Decision Maker). ¶ 2 The Issuer has not filed the following periodic disclosure required by the Legislation: 1. annual audited financial statements for the year ended October 31, 2022, 2. annual management’s discussion and analysis for the year ended October 31, 2022, 3. certification of annual filings for the year ended October 31, 2022. ¶ 3 As a result of this order, if the Issuer is a reporting issuer in a jurisdiction in which Multilateral Instrument 11-103 Failure-to-File Cease Trade Orders in Multiple Jurisdictions applies, a person or company must not trade in or purchase a security of the Issuer in that jurisdiction, except in accordance with the conditions that are contained in this order, if any, for so long as this order remains in effect. ¶ 4 Further, this order takes automatic effect in each jurisdiction of Canada that has a statutory reciprocal order provision, subject to the terms of the local securities legislation. Interpretation ¶ 5 Terms defined in the Legislation, National Instrument 14-101 Definitions and National Policy 11-207 Failure-to-File Cease Trade Orders and Revocations in Multiple Jurisdictions have the same meaning if used in this order, unless otherwise defined. Order ¶ 6 Each of the Decision Makers is satisfied that the decision concerning the cease trade meets the test set out in the Legislation to make this decision. ¶ 7 It is ordered under the Legislation that trading cease in respect of each security of the Issuer. ¶ 8 Despite this order, a beneficial securityholder of the Issuer who is not, and was not at the date of this order, an insider or control person of the Issuer, may sell securities of the Issuer acquired before the date of this order if both of the following apply: 1. the sale is made through a “foreign organized regulated market”, as defined in section 1.1 of the Universal Market Integrity Rules of the Investment Industry Regulatory Organization of Canada; and 2. the sale is made through an investment dealer registered in a jurisdiction of Canada in accordance with applicable securities legislation. ¶ 9 March 6, 2023 Michael Moretto Michael Moretto, CPA, CA, CPA (Illinois) Deputy Director, Corp

BCSC Logo

CEASE TRADE ORDERS
EMERGENCE GLOBAL ENTERPRISES INC. [CEASE TRADE ORDER]
BCSECCOM #:

2023 BCSECCOM 107

Document Type:

Cease Trade Order

Published Date:

2023-03-06

Effective Date:

2023-03-06

Details:

2023 BCSECCOM 107 ??

Click on the Adobe icon to launch the Acrobat Reader

https://www.bcsc.bc.ca/.../2023/2023-BCSECCOM-107.pdf...

BCSC Logo

CEASE TRADE ORDERS
EMERGENCE GLOBAL ENTERPRISES INC. [CEASE TRADE ORDER]
BCSECCOM #:

2023 BCSECCOM 107

Document Type:

Cease Trade Order

Published Date:

2023-03-06

Effective Date:

2023-03-06

Details:

2023 BCSECCOM 107

Stohlman and another fitx original got busted in Georgia over mortgage fraud back in the day. They claimed proceeds from their stock sales as “income” and that’s not legal.

Why did emergence get halted?

Bills lying lawyer ,Bills Bankruptcies,Bills resignation and Bills patsy is the Ceo of Cen
Biotech now!

There's like 9 can biotech groups on Facebook only 1 has current news for the public

These stocks are proven Chaaban Family number cookers . No shareholder ever benefits. Always excuses and resignations and always someone plugged in with questionable character.

Thank you for what you do just wanted to say a few of us follow you and care about the interesting things you post. I tried to tell you but the Fitx moderator keeps deleting my post and sent me nasty private messages to go away from ihub.

EIN Presswire
There were 1,763 press releases posted in the last 24 hours and 375,448 in the last 365 days.

Emergence Global provides Shareholder Update
NEWS PROVIDED BY
Emergence Global Enterprises Inc.
March 01, 2023, 10:19 GMT
SHARE THIS ARTICLE

Emergence Global Enterprises Inc. (OTCQB:ELOAF)

ESSEX, ONTARIO, CANADA, March 1, 2023 /EINPresswire.com/ -- Emergence Global Enterprises Inc. (CSE: EMRG, OTCQB: ELOAF) (“Emergence Global” or the “Company”), a leading innovator in the emerging growth sector of vertical farming, today issued a shareholder update. In the fiscal year 2021, the Company completed its pivot to food security by acquiring a state-of-the-art vertical farm and greenhouses on a sprawling 18.88 acres of land outside Edmonton, Alberta, Canada. The portfolio was further strengthened in fiscal 2022 by the acquisition of 150 patented orbital grow units, and culminated with the IP acquisition of Alvera Inc. patent portfolio.

The Company's strategic acquisitions, combined with a change in financial controls and additions to our management team, have resulted in the need for additional time to complete the audit of our financial reports by our independent public accounting firm in order to conclude our financial reporting requirements for our fiscal year ended October 31, 2022. This delay will result in a temporary cease trade order in the province of British Columbia, which will be automatically lifted once the company posts its year-end financials.

"We apologize for the delay in completing our year-end financial reports and for any inconvenience this may cause our shareholders," said Emergence Global CEO, Joe Byrne. "We want to assure our shareholders that we are working diligently to rectify the situation as quickly as possible. It's important to note that the delay is not the result of any adverse situation related to the company or its operations."

Regulatory authorities have been notified of the delay, and Emergence Global is fully committed to filing its required continuous disclosure reports in the upcoming weeks. The Company looks forward to continuing its efforts to provide long-term value to its shareholders and advancing its position as a leader in the emerging growth sector of vertical farming.

For further information on the Company, please contact Joseph Byrne, Chief Executive Officer and Director phone at: 519-257-0460 or by email at: joe@emergenceglobalinc.com.


Cautionary Statement Regarding Forward-Looking Information

This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to the business and operations of the Company after acquisition of the Assets and any impact therefrom. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to general business, economic, competitive, political, and social uncertainties; delay or failure to receive board, shareholder or regulatory approvals; and the uncertainties surrounding the nutraceutical and botanical industry. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. There can be no assurance that the proposed transaction will occur or that the anticipated financial, economic, or strategic benefits will be realized.
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) nor OTC Markets accepts responsibility for the adequacy or accuracy of this press release.
Sukhinderpaul Kalsi
Emergence Global Enterprises Inc.
cfo@emergenceglobalinc.com


You just read:

Emergence Global provides Shareholder Update
NEWS PROVIDED BY
Emergence Global Enterprises Inc.
March 01, 2023, 10:19 GMT
SHARE THIS ARTICLE

https://www.einpresswire.com/article/619595500/emergence-global-provides-shareholder-update
Distribution channels: Agriculture, Farming & Forestry Industry

EIN Presswire's priority is source transparency. We do not allow opaque clients, and our editors try to be careful about weeding out false and misleading content. As a user, if you see something we have missed, please do bring it to our attention. Your help is welcome. EIN Presswire, Everyone's Internet News Presswire™, tries to define some of the boundaries that are reasonable in today's world. Please see our Editorial Guidelines for more information.

Contact
Sukhinderpaul Kalsi
Emergence Global Enterprises Inc.
cfo@emergenceglobalinc.com
More From This Source
Emergence Global provides Shareholder Update
View All Stories From This Source






User Agreement

Privacy Policy

Copyright Policy
© 1995-2023 Newsmatics Inc. dba EIN Presswire
All Right Reserved.

We use cookies for analytics, personalized content and ads. By continuing to browse this site, you agree to this use. Learn more

Fitx lawyer Eloaf CEO already apologizing for not having fins for Eloaf shareholders.
Meanwhile trolls are trying to blame Addison still

They are not in the Acmpr..

The Eloaf filing was a hoot you mean they are apologizing for not having their numbers in order with yet again. Also they are involved with Mj in Canada? Where did we hear this story before? Oh yeah Fitx - Cenbf

The Eloaf filing was a hoot you mean they are apologizing for not having their numbers in order with yet again. Also they are involved with Mj in Canada? Where did we hear this story before? Oh yeah Fitx - Cenbf

S1 registration June 19 , 2020 CEN Biotech 43 million

Did you see the S1 the other half of the Fitx team filed with CEN Biotech you see that Deficiency Bahige Chaaban is claiming?

Any news on the Joel Stohlman case?

Lamia Chaaban puts out less prs than Bill

AGREEEED

Elon Musk took over Twitter, it's like Gold right now best reliable social media site as of now and most credible now.

Is Jerry invested in Eloaf like Fitx and Cenbf?

Lamia Chaaban and the Chaabans we're friends with the Stohlmans I heard.

Right stay tuned while Lamia & Bill live off of Shareholders money. Fake numbers with CEN Biotech

Everyone is laughing at the Deficiency Bill left when he resigned leaving CEN Biotech yes that's being talked about stay tuned.

How's the email campaign going? It sort of reminds me of the streaking scene in Old School when he turns around and he's the only one lmfao.

This company is doing good things. Stay tuned.

everyone needs to email in every single day until they recheck all those numbers on the S 1 registration and make sure 43 46 million was really spent getting this company up and running for investor's.

And if not they should pay back all the investors back there money. They should also be banned from the market's.snd any and all occupational licenses they hold should be revoked.

This not only goes for the Bod but anyone working in concert with them if it turns out these books were cooked. This responsibility falls on every Creative Edge / Cen Biotech Shareholder.

46 million no way imo Time 4 #Chaabanrecount

The Company had an accumulated deficit of $46,221,218 At June 30, #S1 #FILINGS #SEC #FINRA 2022 $fitx $cenbf $eloaf #stocks #financials @GaryGensler @HopeLefeber @BillChaaban

The Company had an accumulated deficit of $46,221,218 At June 30, 2022

Look at Brian Payne Thomas Canning receivership bankruptcy and lawsuit from farmers just the type of guy DUMB enough to attach his name and reputation to this outrageous financial filing this needs to be looked at and if he's dumb enough to want to own it ??

46 million dollar debt for CEN Biotech is this true. I don't think Bill should be allowed to resign and exit without a thorough investigation. This should be presented as some Gaffe that Brian Payne and his new team and new financial auditors to clean up. This is a lot of money. I want to hear Bills explanation he entered these figures on the S1 Form with the sec & finra he has to own these numbers imo not Brian Payne and the new handpicked names who is he kidding?

https://www.facebook.com/groups/fitxcenbiobreed/permalink/5080103565435364/

CEN Biotech, Inc. (the “Company”) has determined that it is unable to file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2022 (the “Form 10-Q”) by August 15, 2022, the original due date for such filing, without unreasonable effort or expense because it requires additional time to complete its financial statements. This delay principally relates to completing the accounting process due to a new accounting system which was implemented by the Company subsequent to the end of the first fiscal quarter of 2022. The new accounting system is causing a delay in completing the financial statements because the Company, as well as its accountants are still coordinating the process through the new accounting system. The Company expects that it will file the Form 10-Q no later than the fifth calendar day following the prescribed filing date.

Will be interesting to see how Brian proceeds with those figures reported in the S1 is Brian going to own it so interested and want to hear the splaining of that 42 million so bad!

Brian Payne is doing the right thing here by giving a fitx investor his money back https://www.facebook.com/groups/fitxcenbiobreed/permalink/5036631196449268/

Let's see if that Deficiency is still there. Brian if is there we are going to ask how did they accumulate it and how did that happen? Could you give shareholders an itemized report? And if it disappears we are going to ask where it went? We expect you to have answers regardless. It all falls on the man in charge and you put yourself in that position Brian? We expect you to tell us the truth.

Look at how many millions were supposedly put into the Business you think it's time a for Brian to shed some light on that now that he's in Charge of cen Biotech? It's his fiduciary duty to tell us if that's true and how they came up with that 42 million dollar Deficiency in the S1?

When are the rest of Fitx investors getting there money back there's a pandemic and a recession coming they deserve their money back. Bill lied there's no huge company debt. He cant show that he spent that money on company operations and lost it. Why did he resign and have Brian fire the accounting company? Anyone even wondering?